Closing Remarks

  • Elizabeth C. Miller
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 197)


In closing this stimulating and most interesting conference I first wish to express the thanks of all of the participants to the organizers, especially Dr. Snyder and Dr. Nelson, for their foresight and skill in planning and developing this Third International Symposium on Biological Reactive Intermediates. The Symposium has fulfilled the most important goal of such a conference -- i.e., to bring together in a strongly interactive manner persons carrying out research at the forefront of a field. Based on the quality of the talks and the discussions, both formal and informal, I am confident that this meeting, like its predecessors in 1975 and 1980, will have a major role in stimulating further important advances in our knowledge of biological reactive intermediates and the use of this knowledge for solving problems relevant to human health.


Epidermal Growth Factor Receptor Transforming Virus Xenobiotic Chemical Mutagenic Lesion Acetic Acid Ester 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aaronson, S. A., Robbins, K. C., and Tronick, S. R., 1985, Human protooncogenes, growth factors, and cancer, in: “Mediators in Cell Growth and Differentiation”, p. 241, R. J. Ford and A. L. Maizel, eds., Raven Press, New York.Google Scholar
  2. Adesnik, M., and Atchison, M., 1985, Genes for cytochrome P-450 and their regulation, CRC Reviews in Biochemistry, in press.Google Scholar
  3. Balmain, A., 1985, Transforming ras oncogenes and multistage carcinogenesis, Brit. J. Cancer, 51: 1.PubMedCrossRefGoogle Scholar
  4. Bishop, J. M., 1982, Retroviruses and cancer genes, Adv. Cancer Res., 37: 1.PubMedCrossRefGoogle Scholar
  5. Black, S. D., and Coon, M. J., 1985, Comparative structures of P-450 cytochromes, in: “Cytochrome P-450: Structure, Mechanism, and Biochemistry,” in press, P. R. Ortiz de Montellano, ed., Plenum Press, New York.Google Scholar
  6. Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., and White, R. L., 1983, Expression of recessive alleles by chromosomal mechanisms in retinoblastoma, Nature (London), 305: 779.CrossRefGoogle Scholar
  7. Conney, A. H., 1982, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes memorial lecture, Cancer Res., 42: 4875.PubMedGoogle Scholar
  8. Conney, A. H., Miller, E. C., and Miller, J. A., 1956, The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene, Cancer Res., 16: 450.PubMedGoogle Scholar
  9. Conney, A. H., Miller, E. C., and Miller, J. A., 1957, Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver, J. Biol. Chem., 228: 753.PubMedGoogle Scholar
  10. DiGuiseppi, J., and Fridovich, I., 1984, The toxicology of molecular oxygen, CRC Crit. Rev. Toxicol., 12: 315.CrossRefGoogle Scholar
  11. Fridovich, I., 1983, Superoxide radical: an endogenous toxicant, Ann. Rev. Pharmacol. Toxicol., 23: 239.CrossRefGoogle Scholar
  12. Fuchs, R. P. P., 1984, DNA binding spectrum of the carcinogen N-acetoxyN-2-acetylaminofluorene significantly differs from the mutation spectrum, J. Mol. Biol., 177: 173.PubMedCrossRefGoogle Scholar
  13. Irving, C. C., and Russell, L. T., 1970, Synthesis of the 0-glucuronide of N-2-fluorenylhydroxylamine. Reaction with nucleic acids and with guanosine-5’-monophosphate, Biochemistry, 9: 2471.PubMedCrossRefGoogle Scholar
  14. Jakoby, 1980, “Enzymatic Basis of Detoxication”, Academic Press, New York/ London.Google Scholar
  15. King, C. M., and Allaben, W. T., 1980, Arylhydroxamic acid acyltransferase, in: “Enzymatic Basis of Detoxication,” vol. 2, p. 187, W. B. Jakoby, ed., Academic Press, New York.Google Scholar
  16. Klein, G., and Klein, E., 1985, Evolution of tumours and the impact of molecular oncology, Nature (London), 315: 190.CrossRefGoogle Scholar
  17. Koufos, A., Hansen, M. F., Lampkin, B. C., Workman, M. L., Copeland, N. G., Jenkins, N. A., and Cavenee, W. K., 1984, Loss of alleles at loci on human chromosome 11 during genesis of Wilms’ tumor, Nature (London), 309: 170.CrossRefGoogle Scholar
  18. Loechler, E. L., Green, C. L., and Essigmann, J. M., 1984, In vivo muta-genesis by 06-methylguanine built into a unique site in a viral genome, Proc. Natl. Acad. Sci., U.S.A., 81: 6271.PubMedCrossRefGoogle Scholar
  19. Loveless, A., 1969, Possible relevance of O-6 alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides, Nature (London), 223: 206.CrossRefGoogle Scholar
  20. Maher, V. M., and Reuter, M. A., 1973, Mutations and loss of transforming activity caused by the 0-glucuronide of the carcinogen, N-hydroxy-2aminofluorene, Mutation Res., 21: 63.PubMedCrossRefGoogle Scholar
  21. Marnett, L. J., 1983, Cooxidation during prostaglandin biosynthesis: a pathway for the metabolic activation of xenobiotics, in: “Reviews in Biochemical Toxicology,” vol. 5, p. 135, E. Hodgson, J. R. Bend, and R. M. Philpot, eds., Elsevier Biomedical, New York.Google Scholar
  22. Miller, E. C., Lotlikar, P. D., Miller, J. A., Butler, B. W., Irving, C. C., and Hill, J. T., 1968, Reactions in vitro of some tissue nucle- ophiles with the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene, Mol. Pharmacol., 4: 147.PubMedGoogle Scholar
  23. Miller, E. C., and Miller, J. A., 1981, Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules, Cancer, 47: 2327.PubMedCrossRefGoogle Scholar
  24. Moreno, S. N. J., Mason, R. P., and Docamp, R., 1984, Reduction of Nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase, J. Biol. Chem., 259: 6298.PubMedGoogle Scholar
  25. Müller, R., and Rajewsky, M. F., 1981, Antibodies specific for DNA components structurally modified by chemical carcinogens, J. Cancer Res. Clin. Oncol., 102: 99.PubMedCrossRefGoogle Scholar
  26. Murphree, A. L., and Benedict, W. F., 1984, Retinoblastoma: clues to human oncogenesis, Science, 223: 1028.CrossRefGoogle Scholar
  27. Omenn, G. S., and Gelboin, H. V., 1984, eds. “Genetic Variability in Responses to Chemical Exposure.” Banbury Report 16,“ Cold Spring Harbor Laboratory, Cold Spring Harbor.Google Scholar
  28. Orrenius, S., Thor, H., Dimonte, D., Bellomo, G., Nicotera, P., Ross, D., and Smith, M. T., 1985, Mechanisms of oxidative cell injury studied in intact cells, in: “Microsomes and Drug Oxidations,” p. 238, A. R. Boobis, J. Caldwell, F. De Matteis, and C. R. Elcombe, eds., Taylor & Francis, London.Google Scholar
  29. Ozawa, N., and Guengerich, F. P., 1983, Evidence for formation of an S[2-(N7-guanyl) ethyl]glutathione adduct in glutathione-mediated binding of the carcinogen 1,2-dibromoethane to DNA, Proc. Natl. Acad. Sci., U.S.A., 80: 5266.PubMedCrossRefGoogle Scholar
  30. Pegg, A. E., 1984, Methylation of the 06 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents, Cancer Investigation, 2: 223.PubMedCrossRefGoogle Scholar
  31. Poirier, M. C., 1981, Antibodies to carcinogen-DNA adducts, J. Natl. Cancer Inst., 67: 515.PubMedGoogle Scholar
  32. Poland, A., and Knutson, J. C., 1982, 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity, Ann. Rev. Pharmacol. Toxicol., 2: 517.CrossRefGoogle Scholar
  33. Randerath, K., Haglund, R. E., Phillips, D. H., and Reddy, M. V., 1984, 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole, and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice, Carcinogenesis (London), 5: 1613.Google Scholar
  34. Randerath, K., Reddy, M. V., and Gupta, R. C., 1981, 32P-labeling test for DNA damage, Proc. Natl. Acad. Sci., U.S.A., 78:6126.PubMedCrossRefGoogle Scholar
  35. Sims, P., Grover, P. L., Swaisland, A., Pal,K., and Hewer, A., 1974 Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide, Nature (London), 252: 326.CrossRefGoogle Scholar
  36. Singer, B., 1984, Alkylation of the 06 of guanine is only one of many chemical events that may initiate carcinogenesis, Cancer Investigation, 2: 233.PubMedCrossRefGoogle Scholar
  37. Singer, B., and Grunberger, D., 1983, “Molecular Biology of Mutagens and Carcinogens,” Plenum Press, New York/London.Google Scholar
  38. Singer, B., and Kusmierek, J. T., 1982, Chemical mutagenesis, Ann. Rev. Biochem., 51: 655.PubMedCrossRefGoogle Scholar
  39. Sundheimer, D. W., White, R. D., Brendel, K., and Sipes, I. G., 1982, The bioactivation of 1,2-dibromoethane in rat hepatocytes: covalent binding to nucleic acids, Carcinogenesis, 3: 1129.PubMedCrossRefGoogle Scholar
  40. Troll, W., and Wiesner, R., 1985, The role of oxygen radicals as a possible mechanism of tumor promotion, Ann. Rev. Pharmacol. Toxicol., 25: 509.CrossRefGoogle Scholar
  41. Weinberg, R. A., 1982, Oncogenes of spontaneous and chemically induced tumors, Adv. Cancer Res., 36: 149.PubMedCrossRefGoogle Scholar
  42. Zarbl, H., Sukumar, S., Arthur, A. V., Martin-Zanca, D., and Barbacid, M., 1985, Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-Nmethylurea during initiation of mammary carcinogenesis in rats, Nature (London), 315: 382.CrossRefGoogle Scholar
  43. Ziegler, D. M., 1980, Microsomal flavin-containing monooxygenase: Oxygenation of nucleophilic nitrogen and sulfur compounds, in: “Enzymatic Basis of Detoxication,” vol. 1, p. 201, W. B. Jakoby, ed., Academic Press, New York.Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Elizabeth C. Miller
    • 1
  1. 1.McArdle Laboratory for Cancer ResearchUniversity of Wisconsin Medical School MadisonUSA

Personalised recommendations